PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

Autor: Brault, L1, Menter, T2, Obermann, E C2, Knapp, S3, Thommen, S1, Schwaller, J1, Tzankov, A2
Zdroj: British Journal of Cancer. 7/24/2012, Vol. 107 Issue 3, p491-500. 10p. 1 Diagram, 2 Charts, 4 Graphs.
Databáze: Academic Search Ultimate